drugset / Trial / NCT00685139

Fasting Bioavailability Study of Zonisamide Capsules

NCT00685139

Phase 1 Completed 34 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of this study is to evaluate and compare the relative bioavailability of a test formulation of zonisamide capsules to an equivalent dose of a reference formulation, Zonegran® (zonisamide) capsules, after a single oral dose administered under fasting conditions.

Timeline

Start
2005-01
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 100 mg Oral

Indications

No indication recorded.